author-photo

Ulrich Duehrsen

Saarland University

6

Papers

102

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Real life experience with ATRA-arsenic trioxide based regimen in acute promyelocytic leukemia - results of the prospective German intergroup Napoleon registry

2017 Onkologie
Show All
- Source
- Cite
- Save
Citations (0)
Response Adapted Assignment of the Number of Chemotherapy Cycles for the Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Is Not Justified: Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

2007 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Six vs. Eight Cycles of Bi-Weekly CHOP-14 with or without Rituximab for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the Completed RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

2006 Blood
Show All
- Source
- Cite
- Save
Citations (32)
Dose-escalated CHOP plus etoposide (Hi-CHOEP) is not superior to base-line CHOEP in young good-prognosis patients with aggressive lymphoma: Results of a randomized DSHNHL trial

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Six, Not Eight Cycles of Bi-Weekly CHOP with Rituximab (R-CHOP-14) Is the Preferred Treatment for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

2005 Blood
Show All
- Source
- Cite
- Save
Citations (59)